MYRIAD GENETICS INC·4

Oct 2, 9:10 AM ET

Sanders Walter Lloyd 4

4 · MYRIAD GENETICS INC · Filed Oct 2, 2018

Insider Transaction Report

Form 4
Period: 2018-09-30
Sanders Walter Lloyd
President Myriad Oncology
Transactions
  • Disposition to Issuer

    Common Stock

    2018-09-30$46.00/sh629$28,93436,824 total
  • Disposition to Issuer

    Common Stock

    2018-09-30$46.00/sh629$28,93436,195 total
Footnotes (1)
  • [F1]Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT